Citius Pharmaceuticals Inc
NASDAQ:CTXR
| Market Cap (Intraday) | 16.68M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 4.22 |
| 10-Day MA | $1.70 |
| 50-Day MA | $1.06 |
| 200-Day MA | $3.72 |
Citius Pharmaceuticals Inc Stock, NASDAQ:CTXR
11 Commerce Drive, 1st floor, Cranford, New Jersey 07016
United States of America
Phone: +1.908.967.6677
Number of Employees: 23
Description
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.